An angel investor allocated $2,000,000 across 4 early-stage biotech startups. The first received 30%, the second 25%, the third 20%, and the remainder to the fourth. If the fourth startup’s funding was used to grow at a compound rate of 20% annually, what was its value after 3 years?

Thu, 30 Apr 2026 02:30:10 +0000

Content under review